"The guideline covers how health and social care for older people with multiple long-term conditions should be planned and delivered. It addresses how those responsible for commissioning, managing and providing health and social care should work together to deliver safe, high-quality services."
Costing statement:Implementing the NICE guideline on social care of older people with social care needs and multiple long-term conditions (NG22)
NICE
November 2015
Read more here.
QIPP (Quality, Innovation, Productivity and Prevention) aims to help NHS organisations deliver higher quality care and operate more efficiently and effectively. The Royal Free London NHS Foundation Trust has set up a programme to implement QIPP across the trust. This blog, delivered by the RFH Medical Library, will highlight latest papers about QIPP to support the Trust as they carry out this work.
Showing posts with label costing statement. Show all posts
Showing posts with label costing statement. Show all posts
Tuesday, 17 November 2015
Friday, 5 December 2014
Costing statement - diagnosis and management of community and hospital acquired pneumonia in adults
"Savings may be achieved because of more appropriate use of antibiotics, reduced repeat appointments in primary care and reduced length of stay in secondary care."
Costing statement: Pneumonia – diagnosis and management of community- and hospital acquired pneumonia in adults
Implementing the NICE guideline on pneumonia (CG191)
NICE
December 2014
Read more here.
Costing statement: Pneumonia – diagnosis and management of community- and hospital acquired pneumonia in adults
Implementing the NICE guideline on pneumonia (CG191)
NICE
December 2014
Read more here.
Costing statement: Intrapartum care: care of healthy women and their babies during childbirth
"Implementing the recommendations in the guideline is expected to lead to more women giving birth in settings other than obstetric units than is currently the case. CCGs and hospital trusts should work together to consider the impact this would have on planning service provision."
Costing statement: Intrapartum care: care of healthy women and their babies during childbirth
Implementing the NICE guideline on intrapartum care (CG190)
NICE
December 2014
Read more here.
Costing statement: Intrapartum care: care of healthy women and their babies during childbirth
Implementing the NICE guideline on intrapartum care (CG190)
NICE
December 2014
Read more here.
Monday, 3 November 2014
Implementing the NICE guideline on gallstone disease
"The guideline may have resource implications at a local level as a result of variation in clinical practice across the country. Therefore, we encourage organisations to evaluate their own practices against the recommendations in the NICE guideline and assess costs and savings locally. "
Costing statement: Gallstone disease: Implementing the NICE guideline on gallstone disease (CG188)
NICE
October 2014
Read more here.
Costing statement: Gallstone disease: Implementing the NICE guideline on gallstone disease (CG188)
NICE
October 2014
Read more here.
Multiple sclerosis: costing statement (NICE)
"This costing statement considers the cost implications of the recommendations made in Multiple sclerosis: management of multiple sclerosis in primary and secondary care"
Costing statement: Multiple sclerosis: management of multiple sclerosis in primary and secondary care
NICE
October 2014
Read more here.
Costing statement: Multiple sclerosis: management of multiple sclerosis in primary and secondary care
NICE
October 2014
Read more here.
Implementing the NICE guideline on acute heart failure
"Implementation of the guideline should lead to improved management of acute heart failure and may lead to the following savings and benefits..."
Costing statement: Acute heart failure: Implementing the NICE guideline on acute heart failure (CG187)
NICE
October 2014
Read more here.
Costing statement: Acute heart failure: Implementing the NICE guideline on acute heart failure (CG187)
NICE
October 2014
Read more here.
Monday, 6 October 2014
Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers
"Self-monitoring through use of CoaguChek XS or InRatio2 PT/INR coagulometers has the potential to be cost-saving for CCGs as the increased frequency of INR monitoring may improve health outcomes by enabling the dose of therapy to be adjusted more accurately, thereby avoiding adverse events that can result from an inappropriate dose of long-term vitamin K antagonist therapy, such as stroke and major haemorrhage."
Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers: costing statement
NICE
September 2014
Read more here.
Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers: costing statement
NICE
September 2014
Read more here.
Subscribe to:
Posts (Atom)